>>> premarkets and unconfirmed Broker Changes

BAML

LOREAL - 5.5% Q4 LfL v 4.95. Would buy NESNs 23% stake in cosmetics co (175)+2%

SAFE - BAML UPGRADE to Buy; more +ve appraisal of industry fundamentals(489)+1%

BIG YELLOW - BAML UPGRADE to Buy from Neutral with a new PO of 833p (840)...+1%

KINGSPAN - BAML UPGRADE to Buy from Neutral and raise PO from E36 to E45(35)+1%

ORION - BAML UPGRADE to Buy. Guidance disappointing but nothing changed (27)+1%

GAS NAT - CVC seeking loan of €1.4b to acquire Repsol’s Gas Nat stake (18)...+1%

MEDIOBANCA - Strong rev beat and inc. payout target post capital update (10)+1%

REPSOL - Spec CVC seeking loan of €1.4b to acquire Repsol’s Gas Nat stake(14)u/c

MAERSK - U/l profit at low end of cons but majority due to its acq. (10360).u/c

VICTREX - Sales +41% y/y & vols +30% y/y. Rev helped by a positive FX (2412)u/c

MINERS - Copper -0.5%, Iron ore fut -2.1% with BHP OZ -1.1%, RIO OZ -0.88%..-1%

UMICORE - BAML DOUBLE U/G to Buy and ests upgrade of +12/26% in '18/19 (40).-2%

AMUNDI - Net profit 20%, net fees 1% ahead but flows no disappointing (70)..-2%

CECONOMY - Earnings €145m v €173m cons. Group reits its FY guidance (10.9)..-2%

 

MainFirst
*L'OREAL-FY Rev 26.02b(26.07),OP 4.68b(4.71),wld + Nestle stake.....+1%

*RUBIS-Rev €3.93b(3.92),Q4 Rev €1.11b(1.15),Energy Bizz vol +27%....+0.5%

*EMS CHEMIE-FY Sales 2.15b(2.12),Ebit 582m(575.8),o/lk ok...........+0.5%

*TARKETT-FY Sales 2.84b(2.84),Ebitda 315m(308),sees '18 stable......-1%

*MEDIOBANCA-Q2 Rev 571.5m(548),Net 175.4m(150),cutting Generali.....+1%

*CECONOMY-Q1 Sales 6.94b(6.93),Ebitda 315m(348),Confirms FY.........-1%

*ATLANTIA-Is said to have funding to raise Abertis bid €19 plus.....-1%

*MAERSK-FY Ebit 641m(1.03),Ebitda 3.53b(3.64),Rev 30.9b(31.96)......-10%

*DEL HERO-ABB 3.972m shs at €30.75-€32.60 vs clse €32.60............-2%

*UMICORE-ABB 22.4m shares at €39.8 vs close €40.90..................-2.5%

*STORA ENSO-Q4 Ebit 280m(272.4),Sales 2.51b(2.55),Div 41c(40).......+1%

 

 

SHB

MAERSK ->5% q4 revs $8.174b (CONS 8.028); EBITDA $3.53B (CONS 3.64)

Entra   +4% Q4 rental income 1% above cons, operating profit 19% above cons,

FINGB  -5% Q4 bang in line with recent warning. Sees revs continue declining.

BUFAB  +2% q4 sales sek828m (CONS 762 [only 2]); op prof sek69m (CONS 62)

MEKO   -1% q4 sales sek1.51b (CONS 1.48); adj EBIT sek103m (CONS 104)

FRED   -5% q4 rev $50m (CONS 47.2) EBITDA $10m (CONS 11.2)

NPRO   -3% Q4 Rental inc 2% below cons, op profit 4% below cons

BERGMAN mp q4 revs sek954m (cons 956) OP prof 53m (CONS 49)

DUNI   -2%  q4 sales sek1.25b says price comp hasn’t fully offset pulp prices

MMGRB  +2%  Sales +4% beat and adj EBIT +29% Margin 5.1% vs 4.1 cons

 

CS
Amundi        M/P    Q4 revs slightly ahead, div better, outlook conservative

Anima         M/P    FY Revenues 1.5% ahead, EBITDA 3% ahead

Drax          M/P    Yesterdays capacity auction adds about 3% to 2022 EBITDA

Flow Traders +15%    Q4 Revs 6% ahead, EBITDA 18% ahead, strong start to 2018

Kinnevik      M/P    4Q net asset value per share SEK329, div relatively inline

L'Oreal      +3-5%   Sales growth ahead, CEO talking about buying Nestle stake

Maersk       -1-2%   FY underlying profit $356m vs cons $425.4m, guidance light

Miners        UNCH   Copper -0.60%, Brent -0.25%, Iron Ore -1.50%, China -5.50%

Sanofi        -1%    LOREAL own 10% of SANOFI, may sell to buy back Nestle stake

Umicore       +1%    H2 earnings and 10% equity placing

Victrex      +2-3%   Q1 40% growth in sales, ahead of CS ests